CorTec GmbH, private developer and contract manufacturer of implantable neurotechnology including investigational Brain Interchange recording/stimulation. Current CEO Frank Desiere; co-founder/CTO Martin Schuttler. Keep EIC grants separate from equity.
Founded 2010
team@apexlogos.ai · yesterday
RELATED team@apexlogos.ai · yesterday
BCI research snapshot, reviewed 2026-10-06. Company identity: CorTec. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts.
Part 1/1
# CorTec
Reviewed 2026-10-06. Proposed ID: `CorTec`. Research only.
## Identity and import decision
**Validated company; propose a new company after review.** CorTec GmbH; [official site](https://cortec-neuro.com/ ); founded 2010; Freiburg, Germany. Private clinical-stage developer of implantable neurotechnology and a contract development/manufacturing business. [Company About](https://cortec-neuro.com/about ), [legal entity](https://cortec-neuro.com/privacy-statement/ ).
Read-only `Org` search found no CorTec match. Do not merge with Cortec Group (US private equity) or Cortec Corporation (corrosion products).
## Audit of pasted entry
Freiburg, active status and **Brain Interchange** product are supported. The product is investigational, a surface-of-brain recording/stimulation BCI rather than a commercially approved restorative therapy. CEO was omitted: **Frank Desiere**, appointed March 25, 2025. **Oliver Bärtl is current CFO/COO**, despite stale databases describing him as CEO. Historical founder/managing director Jörn Rickert is not listed on the current management page. [Appointment](https://cortec-neuro.com/news/cortec-welcomes-dr-frank-desiere-as-chief-executive-officer ), [current team](https://cortec-neuro.com/about/people ), [BCI status](https://cortec-neuro.com/about/why-cortec ).
## Images and public leadership
Company logo: [direct SVG](https://cortec-neuro.com/media/site/1b1433343f-1788529150/CorTec-Logo.svg ); source [current team HTML](https://cortec-neuro.com/about/people ). Named headshots extracted from each adjacent current team card:
| Person | Role / status | Profile / evidence | Direct pfp URL |
|---|---|---|---|
| Frank Desiere | CEO; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/ba724a0cc8-1788529252/frank_desiere_2025-10-1-1024x681-1.png ) |
| Oliver Bärtl | CFO / COO; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/8d13a12a29-1788529259/bartl_oliver_2025-1024x685.png ) |
| Martin Schüttler | CTO and co-founder; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/25245169ee-1788529256/schuettler_martin_2025-768x514-1.png ) |
| Christoph Mangold | Director; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/4d00ab040c-1788529259/2026_mangold_christoph-1-768x514.png ) |
| Helmut Jeggle | Director; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/b2644fe4e7-1788529261/jeggle_helmut_2025-2048x1371.png ) |
| Heiko Specht | Director; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/5b472bb664-1788529258/2025_specht_heiko_9_website-2048x1318.png ) |
| Pascal Fries | Director; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/7a2b9a8f04-1788529253/fries_pascal_2025-2048x1371.png ) |
| Klaus Würtenberger | Director; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/59ebdecb8e-1788529258/2025_portrait_wurtenberger_blauer_pulli-1-2048x1362.png ) |
| Volker Coenen | Scientific advisor; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/815f1d692b-1788529257/coenen_volker_2025-2048x1371.png ) |
| Alexander Mayr | Scientific advisor; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/ddb9c2038e-1788529256/mayr_alexander_2025-2048x1371.png ) |
| Thomas Stieglitz | Scientific advisor; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/fa5896b29d-1788529255/stieglitz_thomas_2025-2048x1365.png ) |
| Ulf Ziemann | Scientific advisor; current | [Profile](https://cortec-neuro.com/about/people ) | [Photo](https://cortec-neuro.com/media/pages/about/people/989c2c0dcc-1788529261/ziemann_ulf_2025-2048x1365.png ) |
Jörn Rickert is a historical co-founder/CEO in [2019 financing release](https://cortec-neuro.com/news/struengmann-group-invests-in-further-expansion-of-cortec ), but current role/pfp remains unavailable in reviewed current team page. Do not assign a current management position from old financing text.
## Investments and grants
| Date | Amount | Type | Lead / named participants | Evidence |
|---|---:|---|---|---|
| 2016; precise announcement date not established | Undisclosed | Company calls this Series B | Mangold Invest joined existing shareholders; representative Bernhard Meder of M-Invest quoted | [Official round announcement](https://cortec-neuro.com/cortec-plans-to-enter-clinical-studies-with-series-b-financing/ ) |
| 2019-11-07 | EUR 13M | Equity; current official release does not supply series label | Lead Santo Venture Capital; LBBW Venture Capital; several existing shareholders unnamed | [Official release](https://cortec-neuro.com/news/struengmann-group-invests-in-further-expansion-of-cortec ) |
| 2022 October EIC selection cut-off; announcement later | EUR 2.5M | EIC Accelerator grant; separate blended-finance selection | European Innovation Council | [Company release index](https://cortec-neuro.com/author/carolinaremke/page/2/ ), [official EIC selection](https://eic.ec.europa.eu/system/files/2022-12/EIC%20Accelerator-October%205%202022%20Cut%20Off%20v2.pdf ) |
The [current shareholders page](https://cortec-neuro.com/about/shareholders ) additionally establishes HTGF, Mangold Invest, KfW, M-Invest, K & S W Invest and EIC support alongside Santo/LBBW. It gives no dates or company-specific amounts for each relationship; fund sizes/default investment ranges are **not CorTec round amounts**.
Separately, a 2022 consortium study received almost EUR 6M from European Commission EIC Pathfinder and Swiss SERI; **whole consortium funding, not CorTec equity or necessarily CorTec's allocated grant**. [Company project announcement](https://cortec-neuro.com/news/speak-your-mind-pilot-clinical-study ).
## Review caveats
Company and aggregator series labels differ (2016 officially Series B; 2019 sometimes labeled Series B by databases). Preserve official language; avoid double-counting the same EUR 13M round. No verified comprehensive equity total, acquisition or debt round found. EIC blended-finance selection is not evidence of a fully disbursed equity commitment at a specific amount. SHOW MORE
Alexander MayrScientific advisor
Christoph MangoldDirector
Heiko SpechtDirector
Helmut JeggleDirector
Klaus WürtenbergerDirector
Martin SchüttlerCTO and co-founder
Oliver BärtlCFO / COO
Pascal FriesDirector
Thomas StieglitzScientific advisor
Ulf ZiemannScientific advisor
Volker CoenenScientific advisor